rxstat › Shortages › Modafinil

Modafinil shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Modafinil products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 6
In shortage since
Apr 1, 2017
Reports on file
16
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
BIO-MODAFINIL
100MG · TABLET · BIOMED PHARMA
DIN 02442078 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Resolved
TEVA-MODAFINIL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02420260 · ended Jun 24, 2026 · Disruption of the manufacture of the drug.
Discontinued
ALERTEC
100MG · TABLET · TEVA CANADA LIMITED
DIN 02239665
Discontinued
TEVA-MODAFINIL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02420260
Resolved
APO-MODAFINIL
100MG · TABLET · APOTEX INC
DIN 02285398 · ended Apr 3, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-MODAFINIL
100MG · TABLET · APOTEX INC
DIN 02285398 · ended Dec 12, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-MODAFINIL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02420260 · ended Nov 27, 2024 · Disruption of the manufacture of the drug.
Resolved
AURO-MODAFINIL
100MG · TABLET · AURO PHARMA INC
DIN 02430487 · ended Sep 13, 2024 · Demand increase for the drug.
Resolved
APO-MODAFINIL
100MG · TABLET · APOTEX INC
DIN 02285398 · ended Oct 26, 2023 · Disruption of the manufacture of the drug.
Resolved
ALERTEC
100MG · TABLET · TEVA CANADA LIMITED
DIN 02239665 · ended Sep 22, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-MODAFINIL
100MG · TABLET · APOTEX INC
DIN 02285398 · ended Feb 18, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-MODAFINIL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02420260 · ended May 13, 2020 · Disruption of the manufacture of the drug.

Showing 12 of 16 reports. All reports are on file with Health Canada.

What's happening

Modafinil is currently affected by an active shortage report filed with Health Canada by BIOMED PHARMA.

The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Modafinil is classified under “PSYCHOSTIMULANTS AND NOOTROPICS” (ATC N06BA).

Recent changes

Common questions

When will Modafinil be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Modafinil in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (psychostimulants and nootropics)

Partial shortageAtomoxetine13 of 63 reported products affected · est. return Dec 31, 2026Partial shortageDextroamphetamine2 of 6 reported products affected · est. return Jul 20, 2026Partial shortageLisdexamfetamine3 of 18 reported products affected · est. return Jul 24, 2026Partial shortageMethylphenidate7 of 59 reported products affected · est. return Oct 3, 2026Partial shortageMixed Salts Amphetamine3 of 25 reported products affected · est. return Jun 19, 2026No current shortageCaffeine

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.